Sanofi-Aventis to buy Acambis for about $549.5 mln

[MoneyGuy]

SAN FRANCISCO (MarketWatch) -- Sanofi Pasteur Holding, a vaccines division of Sanofi-Aventis , will buy United Kingdom's Acambis PLC for a total of about 276 million pounds ($549.5 million) or 190 pence a share, the pharmaceutical company said Friday. The offer price is a 65% premium to Acambis' share price of 115 pence at the close of business on July 24. Acambis is a London Stock Exchange-listed vaccines company and its portfolio includes a licensed smallpox vaccine.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

http://feeds.marketwatch.com/~a/marketwatch/marketpulse?i=jWhHb5 (http://feeds.marketwatch.com/~a/marketwatch/marketpulse?a=jWhHb5)

http://feeds.marketwatch.com/~f/marketwatch/marketpulse?i=RFuwXJ (http://feeds.marketwatch.com/~f/marketwatch/marketpulse?a=RFuwXJ) http://feeds.marketwatch.com/~f/marketwatch/marketpulse?i=L9HUKj (http://feeds.marketwatch.com/~f/marketwatch/marketpulse?a=L9HUKj) http://feeds.marketwatch.com/~f/marketwatch/marketpulse?i=BANaZj (http://feeds.marketwatch.com/~f/marketwatch/marketpulse?a=BANaZj) http://feeds.marketwatch.com/~f/marketwatch/marketpulse?i=VAas0J (http://feeds.marketwatch.com/~f/marketwatch/marketpulse?a=VAas0J)
http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~4/345831030

More... (http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/345831030/story.aspx)